WebApr 11, 2024 · Background Polypharmacy in older people is steadily increasing and a combination of many medicines may result in adverse effects, especially if the medicines … WebApr 11, 2024 · To disentangle the impact of PIMs from polypharmacy, a test for interaction between polypharmacy and PIM was conducted, and an analysis stratified by baseline …
Non-Pharmacologic Approaches to Reducing Polypharmacy in …
WebClinical medicine faces many challenges, e.g. applying personalized medicine and genomics in daily practice; utilizing highly specialized diagnostic technologies; prescribing costly … WebMar 12, 2024 · Another study from 2016 showed that there are five main causes of malnutrition in the elderly: higher BMI, depressive symptoms, frailty, poor self-rated health, and polypharmacy. Of the five main causes, polypharmacy was a strong indicator of malnutrition in both men and women. (5) billy talking cat
The dangers of polypharmacy and the case for …
WebOct 21, 2024 · Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005;31:4–11. Article Google Scholar Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging. 2009;26:1039–48. WebMar 29, 2024 · The King's Fund. Polypharmacy and medicines optimisation: making it safe and sound. London, 2013. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003;20:817–32. 10.2165/00002512-200320110-00003; Maher RL, Hanlon J, Hajjar ER. Clinical … WebMay 23, 2024 · Polypharmacy is commonly defined as the concurrent use of ≥5 drugs by an individual patient, regardless of the indications for which they have been prescribed. 1 Using this definition, the prevalence of polypharmacy is >15% in the general US population and ≈40% in those aged ≥65 years. 2 The prevalence is even higher among patients with … cynthia felix